KRONOX LAB SCIENCES LTD (KRONOX) financials

KRONOX LAB SCIENCES LTD (KRONOX) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 2008, Kronox Lab Sciences Ltd manufactures High Purity Fine, inorganic chemicals, phosphate, and metallic chemicals[1]

Market Cap: ₹776Cr.
Current Price: ₹209
Stock P/E: 27.2
ROE: 26.8%
ROCE: 36.0%
Book Value: ₹31.3
Dividend Yield: 0.24%
52W High / Low: ₹228/96.0

In Jun 2026, KRONOX LAB SCIENCES LTD (KRONOX) reported sales ₹28.39 Cr and net profit ₹7.30 Cr.

Annual TTM: sales ₹105 Cr, net profit ₹29 Cr.

Shareholding: Promoters 74.21% (Jun 2026), FIIs 0.04% (Jun 2026), DIIs 2.07% (Jun 2026), Public 23.68% (Jun 2026), No. of Shareholders 32,479% (Jun 2026).

KRONOX quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	24.86	24.01	26.13	24.29	25.53	25.27	26.13	28.39
Expenses	16.06	15.65	18.38	16.32	16.88	17.24	16.61	19.40
Operating Profit	8.80	8.36	7.75	7.97	8.65	8.03	9.52	8.99
OPM %	35.40%	34.82%	29.66%	32.81%	33.88%	31.78%	36.43%	31.67%
Other Income	0.36	0.82	0.91	0.87	1.04	1.13	2.15	1.30
Interest	0.00	0.00	0.00	0.00	0.04	0.04	0.04	0.03
Depreciation	0.34	0.36	0.35	0.40	0.47	0.52	0.66	0.45
Profit before tax	8.82	8.82	8.31	8.44	9.18	8.60	10.97	9.81
Tax %	26.64%	26.08%	24.07%	25.71%	27.23%	23.37%	26.98%	25.59%
Net Profit	6.47	6.53	6.32	6.28	6.68	6.59	8.00	7.30
EPS in Rs	1.74	1.76	1.70	1.69	1.80	1.78	2.16	1.97
Raw PDF	—	—	—	—	—	—	—	—

KRONOX profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	50	62	82	96	90	100	101	105
Expenses	39	48	63	74	62	67	67	70
Operating Profit	12	15	20	22	28	33	34	35
OPM %	23%	24%	24%	23%	32%	33%	34%	33%
Other Income	1	1	1	2	2	3	5	6
Interest	0	0	0	0	0	0	0	0
Depreciation	1	2	2	2	1	1	2	2
Profit before tax	12	13	18	22	29	34	37	39
Tax %	27%	26%	26%	26%	25%	26%	26%	—
Net Profit	9	10	14	16	21	25	28	29
EPS in Rs	2.12	2.49	3.49	4.42	5.75	6.86	7.45	7.71
Dividend Payout %	0%	0%	0%	0%	9%	7%	7%	—

KRONOX balance sheet (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	0.25	0.24	0.24	37	37	37	37
Reserves	23	27	40	8	29	53	79
Borrowings	0	4	3	0	0	0	2
Other Liabilities	11	7	13	9	8	9	10
Total Liabilities	34	38	57	54	74	99	128
Fixed Assets	6	9	11	16	26	28	29
CWIP	0	0	0	0	0	1	1
Investments	0	0	0	0	0	0	0
Other Assets	29	28	45	38	47	70	98
Total Assets	34	38	57	54	74	99	128

KRONOX cash flows (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	4	11	9	20	17	31	24
Cash from Investing Activity	-4	-3	-8	-7	-17	-28	-24
Cash from Financing Activity	-0	-7	-1	-13	0	-2	-0
Net Cash Flow	0	1	1	-0	0	0	-0
Free Cash Flow	3	10	5	11	5	28	21
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	65%	100%	70%	117%	87%	120%	98%

KRONOX shareholding pattern (%)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	74.21%	74.21%	74.21%	74.21%	74.21%	74.21%	74.21%	74.21%
FIIs	0.56%	0.49%	0.05%	0.03%	0.03%	0.05%	0.08%	0.04%
DIIs	2.57%	2.20%	2.20%	1.71%	1.93%	2.00%	2.05%	2.07%
Public	22.66%	23.10%	23.54%	24.04%	23.84%	23.74%	23.66%	23.68%
No. of Shareholders	39,792	38,489	37,922	37,569	35,780	34,608	33,469	32,479

KRONOX key ratios
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	110	90	114	71	72	72	76
Inventory Days	70	58	58	61	74	47	66
Days Payable	102	69	89	52	51	54	52
Cash Conversion Cycle	78	79	84	80	94	66	90
Working Capital Days	100	95	122	83	143	65	71
ROCE %	—	50%	51%	50%	52%	44%	36%

KRONOXUpdated 19 Oct 2026, 6:01

Kronox Lab Sciences Ltd

KRONOXUpdated 19 Oct 2026, 6:01

Market Cap

₹776Cr.

Current Price

₹209

High / Low

₹228/96.0

Stock P/E

27.2

ROE26.8%

ROCE36.0%

Book Value₹31.3

Face Value₹10.0

Dividend Yield0.24%

About

Incorporated in 2008, Kronox Lab Sciences Ltd manufactures High Purity Fine, inorganic chemicals, phosphate, and metallic chemicals[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	25.95	0	17.43	0.24	0.32	8.44	24.53	6.38	1.72
Sep 2023	21.02	0	15.16	0.49	0.38	5.97	27.14	4.35	1.17
Dec 2023	20.71	0	14.63	0.02	0.3	5.8	18.28	4.74	1.28
Mar 2024	22.18	0	14.33	0.83	0.29	8.39	29.92	5.88	1.58
Jun 2024	25.19	0	16.98	0.43	0.33	8.31	25.99	6.15	1.66
Sep 2024	24.86	0	16.06	0.36	0.34	8.82	26.64	6.47	1.74
Dec 2024	24.01	0	15.65	0.82	0.36	8.82	26.08	6.53	1.76
Mar 2025	26.13	0	18.38	0.91	0.35	8.31	24.07	6.32	1.7
Jun 2025	24.29	0	16.32	0.87	0.4	8.44	25.71	6.28	1.69
Sep 2025	25.53	0.04	16.88	1.04	0.47	9.18	27.23	6.68	1.8
Dec 2025	25.27	0.04	17.24	1.13	0.52	8.6	23.37	6.59	1.78
Mar 2026	26.13	0.04	16.61	2.15	0.66	10.97	26.98	8	2.16
Jun 2026	28.39	0.03	19.4	1.3	0.45	9.81	25.59	7.3	1.97

Profit & loss

Annual statement₹ Cr.

Year	Sales	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2020	50	39	1	1	12	27	9	2.12
Mar 2021	62	48	1	2	13	26	10	2.49
Mar 2022	82	63	1	2	18	26	14	3.49
Mar 2023	96	74	2	2	22	26	16	4.42
Mar 2024	90	62	2	1	29	25	21	5.75
Mar 2025	100	67	3	1	34	26	25	6.86
Mar 2026	101	67	5	2	37	26	28	7.45
TTM	105	70	6	2	39	—	29	7.71

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	74.21%
FIIs	0.04%
DIIs	2.07%
Public	23.68%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Jun 2024	74.21%	1.56%	4.34%	19.89%
Sep 2024	74.21%	0.56%	2.57%	22.66%
Dec 2024	74.21%	0.49%	2.2%	23.1%
Mar 2025	74.21%	0.05%	2.2%	23.54%
Jun 2025	74.21%	0.03%	1.71%	24.04%
Sep 2025	74.21%	0.03%	1.93%	23.84%
Dec 2025	74.21%	0.05%	2%	23.74%
Mar 2026	74.21%	0.08%	2.05%	23.66%
Jun 2026	74.21%	0.04%	2.07%	23.68%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Other Assets	Total Assets
Mar 2020	0.25	23	0	11	34	6	0	29	34
Mar 2021	0.24	27	4	7	38	9	0	28	38
Mar 2022	0.24	40	3	13	57	11	0	45	57
Mar 2023	37	8	0	9	54	16	0	38	54
Mar 2024	37	29	0	8	74	26	0	47	74
Mar 2025	37	53	0	9	99	28	1	70	99
Mar 2026	37	79	2	10	128	29	1	98	128

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2020	4	-4	0	0
Mar 2021	11	-3	-7	1
Mar 2022	9	-8	-1	1
Mar 2023	20	-7	-13	0
Mar 2024	17	-17	0	0
Mar 2025	31	-28	-2	0
Mar 2026	24	-24	0	0

Key ratios

Historical financial ratios

Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	110	90	114	71	72	72	76
Inventory Days	70	58	58	61	74	47	66
Days Payable	102	69	89	52	51	54	52
Cash Conversion Cycle	78	79	84	80	94	66	90
Working Capital Days	100	95	122	83	143	65	71
ROCE %	—	50%	51%	50%	52%	44%	36%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of KRONOX LAB SCIENCES LTD (KRONOX)?

The reported market capitalisation for KRONOX LAB SCIENCES LTD (KRONOX) is ₹776Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of KRONOX?

The current price shown for KRONOX LAB SCIENCES LTD (KRONOX) on Fincrux is ₹209 with a 52-week high/low of ₹228/96.0.

What is the P/E ratio of KRONOX LAB SCIENCES LTD (KRONOX)?

The stock P/E for KRONOX LAB SCIENCES LTD (KRONOX) is 27.2 on Fincrux, with ROE at 26.8% and ROCE at 36.0%.

What were KRONOX latest quarterly results?

For Jun 2026, KRONOX LAB SCIENCES LTD (KRONOX) reported sales ₹28.39 Cr and net profit ₹7.30 Cr (figures in ₹ crore unless noted).

What are KRONOX annual sales and net profit?

For TTM, KRONOX LAB SCIENCES LTD (KRONOX) shows sales of ₹105 Cr and net profit of ₹29 Cr on the Fincrux profit & loss statement.

Who owns KRONOX LAB SCIENCES LTD (KRONOX)?

Latest shareholding for KRONOX LAB SCIENCES LTD (KRONOX) on Fincrux: Promoters 74.21% (Jun 2026), FIIs 0.04% (Jun 2026), DIIs 2.07% (Jun 2026), Public 23.68% (Jun 2026), No. of Shareholders 32,479% (Jun 2026).

Where can I find KRONOX LAB SCIENCES LTD (KRONOX) financials?

KRONOX LAB SCIENCES LTD (KRONOX) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show KRONOX balance sheet and cash flow?

Yes. The KRONOX LAB SCIENCES LTD (KRONOX) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 19 October 2026 at 6:01